Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.bbadis.2010.03.001 http://scihub22266oqcxt.onion/10.1016/j.bbadis.2010.03.001 20226856!3517663!20226856     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biochim+Biophys+Acta 2010 ; 1802 (12): 1214-8 Nephropedia Template TP {{tp|p=20226856|t=2010. Endogenous ouabain in renal Na(+) handling and related diseases |pdf=|usr=}}{{20226856}} gab.com Text Endogenous ouabain in renal Na(+) handling and related diseases JO: Biochim Biophys Acta http://www.kidney.de/pget.php?&tw=1&pmid=20226856 #FOAvip The Na(+) pump and its Endogenous modulator Ouabain (EO) can be considered as an ancestral enzymatic system, conserved among species ranging from Drosophila to humans, related to Na handling. In this review, we examine how EO is linked with vascular function in hypertension and if it impacts the pathogenesis of heart and renal failure. Moreover, the molecular mechanism of endogenous ouabain-linked hypertension involves the sodium pump/sodium-calcium exchanger duet. Biosynthesis of EO occurs in adrenal glands and is under the control of angiotensin II, ACTH and epinephrine. Elevated concentrations of EO and in the sub-nanomolar concentration range were found to stimulate proliferation and differentiation of cardiac and smooth muscle cells. They may have a primary role in the development of cardiac dysfunction and failure. Experimental data suggest that the Na/K-ATPase alpha(2)-catalytic subunit causes EO-induced vasoconstriction. Finally, maneuvers that promote Na depletion, as diuretic therapy or reduced Na intake, raise the EO levels. Taken together, these findings suggest a key role for EO in body Na homeostasis. Twit Text FOAVip Endogenous ouabain in renal Na(+) handling and related diseases ????Biochim Biophys Acta http://www.kidney.de/pget.php?&tw=1&pmid=20226856 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=20226856 #FOAvip English Wikipedia <ref>{{Cite pmid|20226856}}</ref> Endogenous ouabain in renal Na(+) handling and related diseases #MMPMID20226856 Manunta P; Messaggio E; Casamassima N; Gatti G; Carpini SD; Zagato L; Hamlyn JM Biochim Biophys Acta 2010[Dec]; 1802 (12): 1214-8 PMID20226856show ga The Na(+) pump and its Endogenous modulator Ouabain (EO) can be considered as an ancestral enzymatic system, conserved among species ranging from Drosophila to humans, related to Na handling. In this review, we examine how EO is linked with vascular function in hypertension and if it impacts the pathogenesis of heart and renal failure. Moreover, the molecular mechanism of endogenous ouabain-linked hypertension involves the sodium pump/sodium-calcium exchanger duet. Biosynthesis of EO occurs in adrenal glands and is under the control of angiotensin II, ACTH and epinephrine. Elevated concentrations of EO and in the sub-nanomolar concentration range were found to stimulate proliferation and differentiation of cardiac and smooth muscle cells. They may have a primary role in the development of cardiac dysfunction and failure. Experimental data suggest that the Na/K-ATPase alpha(2)-catalytic subunit causes EO-induced vasoconstriction. Finally, maneuvers that promote Na depletion, as diuretic therapy or reduced Na intake, raise the EO levels. Taken together, these findings suggest a key role for EO in body Na homeostasis. |Adrenal Glands/metabolism/pathology[MESH] |Angiotensin II/metabolism[MESH] |Animals[MESH] |Cell Proliferation/drug effects[MESH] |Diuretics/therapeutic use[MESH] |Drosophila[MESH] |Epinephrine/metabolism[MESH] |Heart Failure/drug therapy/*metabolism/pathology/physiopathology[MESH] |Homeostasis/drug effects[MESH] |Humans[MESH] |Hypertension[MESH] |Kidney/*metabolism/pathology/physiopathology[MESH] |Myocytes, Cardiac/metabolism/pathology[MESH] |Myocytes, Smooth Muscle/metabolism/pathology[MESH] |Ouabain/*metabolism[MESH] |Renal Insufficiency/drug therapy/*metabolism/pathology/physiopathology[MESH] |Sodium-Calcium Exchanger[MESH] |Sodium-Potassium-Exchanging ATPase/*metabolism[MESH] |Sodium/*metabolism[MESH]Endogenous ouabain in renal Na(+) handling and related diseases (epmc).pdf DeepDyve Pubget Overpricing